The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index; none of the 100 sources its claims cite is checked for support yet.
Cargo-Specific Role for Retriever Subunit VPS26C in Hepatocyte Lipoprotein Receptor Recycling to Control Postprandial Triglyceride-Rich Lipoproteins
Open accessAbstract
Background: The copper metabolism MURR1 domains/coiled-coil domain containing 22/coiled-coil domain containing 93 (CCC) complex is required for the transport of low-density lipoprotein receptor (LDLR) and LRP1 (LDLR-related protein 1) from endosomes to the cell surface of hepatocytes. Impaired functioning of hepatocytic CCC causes hypercholesterolemia in mice, dogs, and humans. Retriever, a protein complex consisting of subunits VPS26C, VPS35L, and VPS29, is associated with CCC, but its role in endosomal lipoprotein receptor transport is unclear. We here investigated the contribution of retriever to hepatocytic lipoprotein receptor recycling and plasma lipids regulation. Methods: Using somatic CRISPR/Cas9 gene editing, we generated liver-specific VPS35L or VPS26C-deficient mice. We determined total and surface levels of LDLR and LRP1 and plasma lipids. In addition, we studied the protein levels and composition of CCC and retriever. Results: Hepatocyte VPS35L deficiency reduced VPS26C levels but had minimal impact on CCC composition. VPS35L deletion decreased hepatocytic surface expression of LDLR and LRP1, accompanied by a 21% increase in plasma cholesterol levels. Hepatic VPS26C ablation affected neither levels of VPS35L and CCC subunits, nor plasma lipid concentrations. However, VPS26C deficiency increased hepatic LDLR protein levels by 2-fold, probably compensating for reduced LRP1 functioning, as we showed in VPS26C-deficient hepatoma cells. Upon PCSK9 (proprotein convertase subtilisin/kexin type 9)-mediated LDLR elimination, VPS26C ablation delayed postprandial triglyceride clearance and increased plasma triglyceride levels by 26%. Conclusions: Our study suggests that VPS35L is shared between retriever and CCC to facilitate LDLR and LRP1 transport from endosomes to the cell surface. Conversely, retriever subunit VPS26C selectively transports LRP1, but not LDLR, and thereby may control hepatic uptake of postprandial triglyceride-rich lipoprotein remnants.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Hepatic VPS35L is required for CCC/retriever-linked endosomal recycling of LDLR and LRP1 and for plasma cholesterol homeostasis, while retriever subunit VPS26C selectively supports LRP1 recycling and postprandial triglyceride-rich lipoprotein clearance. VPS26C loss does not impair CCC integrity or raise plasma lipids under chow conditions, but on an LDLR-deficient background it increases plasma triglycerides and delays postprandial TG clearance.
Key findings
- Hepatocyte VPS35L depletion reduced VPS35L by 84%, CCDC22 by 52%, CCDC93 by 48%, and VPS26C by 68%; it reduced COMMD1–VPS26C binding by 90%, impaired LDLR and LRP1 plasma membrane levels, and increased plasma cholesterol by 21%, mainly in LDL fractions with increased apoB100.
- Hepatocyte VPS26C depletion reduced VPS26C protein by 75% without affecting CCC subunits CCDC93, COMMD1, or VPS35L; hepatic LDLR protein was almost doubled, but plasma cholesterol and TG levels were unaffected.
- In Hepa1-6 cells, VPS26C ablation decreased total and cell-surface LRP1 and increased cell-surface LDLR; GST pulldown showed VPS26C interacted with the LRP1 intracellular domain but not the LDLR intracellular domain.
- With LDLR blunted by AAV-PCSK9-D377Y, hepatic VPS26C deficiency increased plasma TG by 26%, mainly in chylomicron remnant/VLDL and IDL/LDL fractions, increased the apoB48/apoB100 ratio, and delayed postprandial TG clearance after an oral fat load, without affecting VLDL secretion or hepatic uptake of VLDL-like particles.
Methods
- Male C57BL/6J littermate mice, 8–12 weeks old, with hepatocyte-specific Cas9 expression were used; Vps35l or Vps26c was targeted in hepatocytes by CRISPR/Cas9 via AAV sgRNAs, and in some experiments LDLR was blunted with AAV-PCSK9-D377Y.
- Phenotyping included oral fat tolerance tests, VLDL-mimicking particle clearance and tissue uptake, VLDL-TG production with poloxamer 407, plasma/liver lipid measurements, FPLC, sucrose gradients, immunoblotting, qRT-PCR, targeted proteomics, immunoprecipitation, biotinylation, and GST pulldown in Hepa1-6, primary hepatocytes, and HEK293T cells.
- Statistical analysis used GraphPad 9.1 with Shapiro-Wilk and F tests, Student/Welch t tests, Mann-Whitney U tests, Holm-Šídák correction, and repeated measures ANOVA with Geisser-Greenhouse correction and Šídák’s multiple comparison test; P<0.05 was considered significant.
Limitations
- The paper states that only male mice were used, to compare with previous studies, and that this is a limitation; it also states that no randomization or blinding methods were used for animal studies.
- The paper states that it cannot rule out other mechanisms explaining increased plasma TG after hepatic Vps26c ablation in an LDLR-deficient background, and that surface LRP1 levels could not be assessed in vivo, so other mechanisms for decreased TG clearance cannot be excluded.
- The paper states that VPS29 was not investigated because it is shared by retriever and retromer, and that future studies are needed to understand cargo specificity, molecular organization, metabolic effects, and whether human VPS35L/VPS26C mutations affect plasma lipids; evident from the text, several experiments used small samples (e.g., n=4–9) and some FPLC analyses used pooled plasma.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 100 cited sources checked · 0 supported · 0 flagged
- Findingown data
Hepatic ablation of VPS35L did not decrease protein levels of COMMD1 and COMMD3.
“Hepatic ablation of VPS35L did not decrease the protein levels of COMMD1 and COMMD3 (Figure 1C and 1D), which was confirmed by targeted proteomics analysis (Figure S1A).”
Quote in the paperSubstantial claim - Findingown data
In mouse livers, VPS35L ablation reduces VPS26C protein levels by 68%.
“reduced by 68% upon VPS35L ablation (Figure 1E).”
Quote in the paperSubstantial claim - Findingnone given
The same level of reduction in VPS26C was observed in mice lacking CCC subunit COMMD1 in their livers.
“The same level of reduction in VPS26C was observed in mice lacking CCC subunit COMMD1 in their livers”
Quote in the paperSubstantial claim - Findingown data
Loss of hepatocytic VPS35L does not affect the cellular distribution of CCDC22 and CCDC93 despite reduced levels of these proteins.
“Despite the reduced levels of CCDC22 and CCDC93 (Figure 1C and 1D), loss of hepatocytic VPS35L did not affect their distribution (Figure 1E).”
Quote in the paperNot a substantial claim - Findingown data
apoB100 levels are increased in the plasma of VPS35L-deficient mice.
“which was supported by increased apoB100 levels in the plasma (Figure 2D).”
Quote in the paperSubstantial claim
- Findingown data
In livers of hepatocyte-specific VPS26C-deficient mice, LDLR protein levels are almost doubled upon VPS26C ablation.
“While LRP1 protein levels were unchanged, we found that LDLR protein levels were almost doubled upon VPS26C ablation (Figure 4A and 4B)”
Quote in the paperSubstantial claim - Findingown data
The apoB48/apoB100 ratio in plasma of hepatic VPS26C-deficient mice with blunted LDLR levels is increased compared with control mice.
“In addition, the apoB48/apoB100 ratio, a marker for remnant lipoproteins, in plasma of hepatic VPS26C-deficient mice with blunted LDLR levels was increased compared with control mice (Inset Figure 6F).”
Quote in the paperSubstantial claim- Rests on an assumption: The apoB48/apoB100 ratio is a valid marker for remnant lipoproteins.
- Findingown data
The increase in LDLR protein levels upon VPS26C ablation cannot be explained by changes in mRNA levels.
“which could not be explained by changes in mRNA levels (Figure 4C).”
Quote in the paperSubstantial claim - Findingown data
Loss of VPS35L reduces the binding between COMMD1 and retriever subunit VPS26C by 90%.
“However, loss of VPS35L reduced the binding between COMMD1 and retriever subunit VPS26C by 90% (Figure 1H)”
Quote in the paperSubstantial claim - Findingown data
The increase in TGs is found mainly in the chylomicron remnants/VLDL and IDL/LDL particle size range.
“FPLC analysis showed that the increase in TGs was found mainly in the chylomicron remnants/VLDL and IDL (intermediate density lipoprotein)/LDL particle size range (Figure 6F).”
Quote in the paperSubstantial claim - Findingnone given
Total LRP1 levels are not reduced upon hepatic Vps26c ablation in mice.
“However, in contrast to our cellular models, the total LRP1 levels are not reduced upon hepatic Vps26c ablation in mice”
Quote in the paperSubstantial claim - Findingown data
The increased TG levels were not caused by changes in VLDL secretion.
“The increased TG levels were not caused by changes in VLDL secretion (Figure 6G)”
Quote in the paperSubstantial claim - Findingown data
Total protein levels of retromer subunits VPS35 and VPS26 are minimally or unaffected by VPS35L deficiency.
“Consistent with this result, total protein levels of retromer subunits VPS35 and VPS26 were minimally or unaffected”
Quote in the paperSubstantial claim - Findingown data
Loss of VPS35L blunts the interaction of retriever subunit VPS29 with the CCC complex.
“and blunted the interaction of retriever subunit VPS29 with the CCC complex (Figure 1H).”
Quote in the paperSubstantial claim - Findingreasoning
Total VPS29 levels in mouse livers are not affected by the loss of VPS35L.
“In contrast, the total levels of VPS29 in mouse livers were not affected by the loss of VPS35L”
Quote in the paperSubstantial claim - Findingown data
TG clearance is significantly delayed in hepatic VPS26C-deficient mice compared with control mice.
“We observed that TG clearance was significantly delayed in hepatic VPS26C-deficient mice compared with control mice (Figure 6H).”
Quote in the paperSubstantial claim - Findingown data
Hepatic levels of VPS35L were decreased by 84% in mice with hepatocyte-specific VPS35L deletion.
“Using this approach, the hepatic levels of VPS35L were decreased by 84%.”
Quote in the paperSubstantial claim - Findingnone given
The reduction of LRP1 levels is not observed in VPS26C-deficient total liver lysates.
“Interestingly, the reduction of LRP1 levels is not observed in VPS26C-deficient total liver lysates.”
Quote in the paperSubstantial claim - Findingown data
Livers of mice lacking CCC subunit COMMD1 show the same reduction in VPS26C as VPS35L ablation.
“The same level of reduction in VPS26C was observed in mice lacking CCC subunit COMMD1 in their livers (Figure 1F).”
- Also stated in: § DISCUSSION · boosted
“Here, we also show that, similar to hepatic loss of VPS35L, deficiency of the CCC component COMMD1 strongly reduces the protein levels of retriever subunit VPS26C.”
Quote in the paperNot a substantial claim - Also stated in: § DISCUSSION · boosted
- Findingown data
Retriever component VPS26C was reduced by 68% upon VPS35L ablation.
“However, retriever component VPS26C was reduced by 68% upon VPS35L ablation (Figure 1E).”
Quote in the paperSubstantial claim - Findingown data
In livers of hepatocyte-specific VPS26C-deficient mice, LRP1 protein levels are unchanged.
“While LRP1 protein levels were unchanged, we found that LDLR protein levels were almost doubled upon VPS26C ablation (Figure 4A and 4B)”
Quote in the paperSubstantial claim - Findingown data
Hepatic ablation of VPS35L results in a 21% increase in plasma cholesterol levels.
“hepatic ablation of VPS35L resulted in a 21% increase in plasma cholesterol levels (Figure 2B).”
Quote in the paperSubstantial claim - Findingown data
In VPS35L-deficient mice, relative cholesterol content is increased mainly in LDL fractions.
“Separation of plasma by fast protein liquid chromatography (FPLC) revealed that the relative cholesterol content was increased mainly in LDL fractions (Figure 2C)”
Quote in the paperSubstantial claim - Findingown data
Hepatic VPS26C deficiency on an LDLR-deficient background decreases postprandial TG clearance.
“Hepatic VPS26C deficiency on a low-density lipoprotein receptor (LDLR)-deficient background increases plasma TG levels and decreases postprandial TG clearance.”
Quote in the paperSubstantial claim - Findingown data
The dyslipidemic phenotype of liver-specific VPS26C-deficient mice with blunted LDLR levels is rather mild compared with that of hepatic CCC knockout mice on an LDLR-deficient background.
“The role of VPS26C in endosomal LRP1 transport under specific metabolic conditions is supported by the observation that the dyslipidemic phenotype of liverspecific VPS26C-deficient mice with blunted LDLR levels is rather mild compared with that of hepatic CCC knockout mice on an LDLR-deficient background.”
Quote in the paperSubstantial claim - Findingown data
Hepatic VPS26C deficiency does not impair CCC complex stability.
“Hepatic VPS26C deficiency does not impair CCC complex stability.”
Quote in the paperSubstantial claim - Findingown data
Loss of hepatic VPS26C does not affect plasma lipids.
“Loss of hepatic VPS26C increases low-density lipoprotein receptor (LDLR) protein levels but does not affect plasma lipids.”
Quote in the paperSubstantial claim - Findingown data
Hepatic VPS26C deficiency on an LDLR-deficient background increases plasma TG levels.
“Hepatic VPS26C deficiency on a low-density lipoprotein receptor (LDLR)-deficient background increases plasma TG levels and decreases postprandial TG clearance.”
Quote in the paperSubstantial claim - Findingown data
Elevated plasma cholesterol has not been observed in hepatic VPS26C-deficient mice.
“a phenotype which has not been observed in hepatic VPS26C-deficient mice.”
Quote in the paperSubstantial claim - Findingown data
Loss of hepatic VPS26C increases LDLR protein levels.
“Loss of hepatic VPS26C increases low-density lipoprotein receptor (LDLR) protein levels but does not affect plasma lipids.”
Quote in the paperSubstantial claim - Premisecitation
Hepatic depletion of CCDC22 or one of the ten COMMD family proteins strongly reduces VPS35L protein levels.
“We showed a strong reduction in VPS35L protein levels upon hepatic depletion of one of the CCC subunits-either CCDC22 or one of the ten members of the COMMD family of proteins 25,38”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [38]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Mutations in protein complexes regulating endosomal sorting result in dyslipidemia in mice, dogs, and humans.
“multiple studies have illustrated that mutations in these protein complexes result in dyslipidemia in mice, dogs, and humans.[24][25][26]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [26]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
VPS26C has a cargo-selective role in CCC/WASH-mediated lipoprotein receptor transport.
“indicating that this retriever component has a cargo-selective role in CCC/WASH-mediated lipoprotein receptor transport.”
Quote in the paperSubstantial claim - Interpretationreasoning
VPS26C mediates LRP1 function.
“suggesting that VPS26C mediates LRP1 function.”
Quote in the paperSubstantial claim - Interpretationcitation
The lack of effect on total VPS29 can likely be explained by its presence in both retriever and retromer.
“but this can likely be explained by its presence in both retriever and retromer.31”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
Retromer is not disturbed by VPS35L deficiency.
“suggesting that retromer is not disturbed by VPS35L deficiency.”
Quote in the paperSubstantial claim - Interpretationcitation
The decrease in LRP1 upon VPS26C ablation is likely due to increased lysosomal degradation due to impaired endosomal recycling of LRP1.
“likely due to increased lysosomal degradation due to impaired endosomal recycling of LRP1, 24”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
This compensation did not lead to reduced plasma LDL cholesterol levels under chow-fed conditions.
“In addition, in line with our results, this compensation did not lead to reduced plasma LDL cholesterol levels under chow-fed conditions.8,9,11”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [11]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
The increased LDLR protein levels could be explained by a post-translational event.
“Since Ldlr expression was not changed, the increased LDLR protein levels could be explained by a post-translational event.”
Quote in the paperSubstantial claim - Premisecitation
Loss of the CCC complex in hepatocytes impairs endosomal recycling of LDLR and LRP1, resulting in hypercholesterolemia.
“We have previously demonstrated that loss of the CCC complex in hepatocytes impairs endosomal recycling of LDLR and LRP1, resulting in hypercholesterolemia. 24,25”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
An increase in apoB48/apoB100 ratio has also been observed in hepatic LRP1-deficient mice on a LDLR knockout background.
“An increase in apoB48/apoB100 ratio has also been observed in hepatic LRP1-deficient mice on a LDLR knockout background, 8”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
VPS35L is apparently still essential for a functional CCC complex to inhibit WASH recruitment and activity.
“However, VPS35L is apparently still essential for a functional CCC complex to inhibit WASH recruitment and activity, 37”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [37]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
VPS26C has a distinct function in the CCC-WASH axis to orchestrate endosomal cargo transport.
“Consistent with prior work, 31,37 our data suggest that VPS26C has a distinct function in the CCC-WASH axis to orchestrate endosomal cargo transport.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [31]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [37]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
This model allows study of the specific role of retriever in LDLR and LRP1 functioning and plasma lipid regulation.
“Thus, this model allows us to study the specific role of retriever in LDLR and LRP1 functioning and plasma lipids regulation.”
Quote in the paperSubstantial claim - Premisecitation
Hepatic deficiency of CCDC22 or any COMMD protein reduces the protein levels of all CCC subunits, including VPS35L and VPS26C, by at least 70%.
“In contrast, hepatic deficiency of CCDC22 or any COMMD protein reduces the protein levels of all CCC subunits, including VPS35L and VPS26C, by at least 70% 24,25 (Figure 1F).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
The increased LDLR is likely due to a compensatory mechanism as reported in previous mouse models with either a loss of LRP1 or impaired LRP1 trafficking.
“likely due to a compensatory mechanism as reported in various previous mouse models with either a loss of LRP1 or impaired LRP1 trafficking.8,9,11,48”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [11]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [48]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
VPS35L seems to be required to connect the CCC complex and retriever with each other.
“and thus seems to be required to connect the CCC complex and retriever with each other.”
Quote in the paperSubstantial claim - Interpretationreasoning
VPS35L and CCC may act together to control plasma cholesterol levels.
“which may suggest that VPS35L and CCC act together to control plasma cholesterol levels.”
Quote in the paperSubstantial claim - Interpretationown data
Hepatic VPS26C is needed for the hepatic clearance of postprandial TG-rich lipoproteins.
“Together, these findings indicate that hepatic VPS26C is needed for the hepatic clearance of postprandial TG-rich lipoproteins.”
Quote in the paperSubstantial claim - Interpretationown data
Both VPS35L and CCC orchestrate the transport of LDLR and LRP1 to the cell surface, thereby controlling plasma cholesterol levels.
“as both VPS35L and CCC orchestrate the transport of LDLR and LRP1 to the cell surface, thereby controlling plasma cholesterol levels.”
Quote in the paperNot a substantial claim - Interpretationown data
Impaired functioning of LRP1 upon hepatic VPS26C deficiency is supported by the increased protein expression of LDLR.
“Impaired functioning of LRP1 upon hepatic VPS26C deficiency is supported by the increased protein expression of LDLR”
Quote in the paperSubstantial claim - Interpretationown data
Hepatic VPS35L mediates the endosomal transport of LDLR and LRP1 to the cell surface, thereby regulating plasma LDL cholesterol levels in mice.
“We show that hepatic VPS35L mediates the endosomal transport of LDLR and LRP1 to the cell surface, thereby regulating plasma LDL cholesterol levels in mice.”
Quote in the paperSubstantial claim - Interpretationreasoning
VPS35L is indispensable for maintaining plasma cholesterol homeostasis.
“thereby, VPS35L is also indispensable for maintaining plasma cholesterol homeostasis.”
Quote in the paperSubstantial claim - Interpretationown data
VPS35L is required for the physical association between the CCC complex and retriever.
“Our data suggest that VPS35L is required for the physical association between the CCC complex and retriever, as VPS35L deficiency decreases VPS26C levels accompanied by abolished binding of the retriever subunit VPS29 to the CCC complex.”
Quote in the paperSubstantial claim - Interpretationown data
Functional assembly of the CCC complex in the CCC-WASH axis does not rely on VPS26C.
“Yet, functional assembly of the CCC complex in the CCC-WASH axis does not rely on VPS26C, as hepatic VPS26C deficiency neither affects CCC integrity, nor results in a hypercholesterolemic phenotype.”
Quote in the paperSubstantial claim - Interpretationcitation
The reduction in LDLR and LRP1 upon VPS35L ablation can probably be explained by impaired endosomal receptor recycling, resulting in increased lysosomal degradation.
“this can probably be explained by impaired endosomal receptor recycling, resulting in increased lysosomal degradation.24,25”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
Hepatic VPS35L is required for the cell surface expression of LDLR.
“Hepatic VPS35L is required for the expression of low-density lipoprotein receptor (LDLR) and LRP1 (LDLR-related protein 1) at the plasma membrane and maintaining plasma cholesterol homeostasis.”
Quote in the paperNot a substantial claim - Interpretationown data
VPS35L is needed for CCC functioning to orchestrate the endosomal transport of LDLR and LRP1 to control plasma cholesterol levels.
“We show that VPS35L is needed for CCC functioning to orchestrate the endosomal transport of LDLR and LRP1 to control plasma cholesterol levels.”
Quote in the paperSubstantial claim - Interpretationown data
VPS26C is required for normal cell surface expression of LRP1.
“VPS26C is required for normal cell surface expression of LRP1 (low-density lipoprotein receptor [LDLR]-related protein 1).”
Quote in the paperSubstantial claim - Interpretationreasoning
These data argue against a role of LPL in elevated plasma TG in hepatic VPS26C-deficient mice.
“Although additional research is needed, these data argue against a role of LPL in elevated plasma TG in hepatic VPS26C-deficient mice.”
Quote in the paperSubstantial claim - Interpretationreasoning
Loss of CCC almost completely impairs hepatic LRP1 functioning.
“suggesting that loss of CCC almost completely impairs hepatic LRP1 functioning.”
Quote in the paperSubstantial claim - Interpretationown data
Hepatic VPS35L is required for the cell surface expression of LRP1.
“Hepatic VPS35L is required for the expression of low-density lipoprotein receptor (LDLR) and LRP1 (LDLR-related protein 1) at the plasma membrane and maintaining plasma cholesterol homeostasis.”
Quote in the paperNot a substantial claim - Interpretationcitation
The endosomal sorting system does not mediate hepatic LPL levels.
“suggesting that the endosomal sorting system does not mediate hepatic LPL levels.”
Quote in the paperSubstantial claim - Interpretationown data
Retriever subunits VPS35L and VPS26C have specific functions in endosomal transport of lipoprotein receptors in hepatocytes.
“Taken together, here, we report for the first time that retriever subunits VPS35L and VPS26C have specific functions in endosomal transport of lipoprotein receptors in hepatocytes.”
Quote in the paperSubstantial claim - Interpretationown data
Hepatic VPS35L is required for maintaining plasma cholesterol homeostasis.
“Hepatic VPS35L is required for the expression of low-density lipoprotein receptor (LDLR) and LRP1 (LDLR-related protein 1) at the plasma membrane and maintaining plasma cholesterol homeostasis.”
Quote in the paperNot a substantial claim - Premisecitation
Hepatic ablation of the WASH subunit Washc1 did not affect the plasma levels of hepatic LPL.
“Moreover, hepatic ablation of the WASH subunit Washc1 did not affect the plasma levels of hepatic LPL, 26”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [26]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
VPS26C specifically orchestrates the surface expression of LRP1 for controlling plasma TG levels in a postprandial state.
“where we show that VPS26C specifically orchestrates the surface expression of LRP1 for controlling plasma TG levels in a postprandial state.”
Quote in the paperSubstantial claim
- It may state two separate claims as one. 56
- Probably not a substantial claim. 48
- The quote only partly states this claim. 1
It may state two separate claims as one.
Findingown dataLoss of hepatic VPS35L reduces CCC core components CCDC93 and CCDC22 by approximately 50% without a profound impact on COMMD proteins, but strongly decreases VPS26C levels.
“Here, we found that loss of hepatic VPS35L reduces CCC core components CCDC93 and CCDC22 by only approximately 50% without a profound impact on COMMD proteins, but it strongly decreases VPS26C levels.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataHepatic VPS26C ablation in an LDLR-deficient background affects neither the hepatic uptake of [3H]TO and [14C]CO-derived activity nor the plasma decay.
“Under these conditions, hepatic VPS26C ablation in an LDLR-deficient background affected neither the hepatic uptake of [ 3 H]TO and [ 14 C]CO-derived activity, nor the plasma decay (Figure S2B and S2C).”
Quote in the paperSubstantial claim- Rests on an assumption: The VLDL-like particles used are representative of endogenous VLDL particles for assessing hepatic uptake.
It may state two separate claims as one.
Findingown dataPlasma cholesterol and TG levels are not affected by Vps26c editing despite increased LDLR protein levels.
“However, despite increased LDLR protein levels, plasma cholesterol and TG levels were not affected by Vps26c editing (Figure 4D through 4F).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataVPS26C ablation in Hepa1-6 cells has no marked effects on the protein expression of CCC subunits, while it slightly increases the subunits of retriever and retromer.
“Using CRISPR/ Cas9 technology, we ablated VPS26C (Figure 5A) and found that its loss had no marked effects on the protein expression of CCC subunits (Figure 5B; Figure S1B), while it slightly increased the subunits of retriever and retromer (Figure 5B; Figure S1C).”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataVPS26C ablation significantly decreases the total levels, as well as the cell surface levels, of LRP1.
“VPS26C ablation significantly decreased the total levels, as well as the cell surface levels, of LRP1 (Figure 5C and 5D; Figure S1D)”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataIn the absence of LDLR, loss of hepatic VPS26C does not affect plasma cholesterol levels or hepatic lipids but significantly increases plasma TG levels by 26%.
“In the absence of LDLR, loss of hepatic VPS26C did not affect plasma cholesterol levels (Figure 6D and 6E) or hepatic lipids (Figure S2A) but significantly increased plasma TG levels by 26% (Figure 6D).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataVPS26C specifically interacts with the ICD of LRP1, but not with the ICD of LDLR.
“Here, we observed a specific interaction between VPS26C and the ICD of LRP1, but not of LDLR (Figure 5E).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataProtein levels of retromer subunits VPS35 and VPS26 were not affected by loss of VPS35L, nor was VPS29.
“The protein levels of retromer subunits VPS35 and VPS26 were also not affected by the loss of VPS35L, nor was VPS29, a subunit of retromer and retriever 31 (Figure 1C and 1D).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Findingown dataHepatocyte VPS26C deletion does not affect the levels of CCC subunits CCDC93, COMMD1, and VPS35L, while CCDC22 tends to increase.
“Although the protein level of the CCC subunit CCDC22 tend to increase upon hepatocyte VPS26C deletion, the level of the other CCC subunits CCDC93, COMMD1, and VPS35L were unaffected, as assessed by Western blot analysis (Figure 3C and 3D).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataIn VPS26C-deficient cells, LRP1 levels are reduced both in the whole-cell lysate and at the plasma membrane, and its binding to LRP1, but not LDLR, is affected.
“This is evident from our results in cells deficient for VPS26C, where LRP1 levels are reduced both in the whole-cell lysate and at the plasma membrane and its binding to LRP1, but not LDLR.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataVPS35L deficiency had only a very mild impact on levels of most COMMD proteins, but COMMD10 levels were decreased by 42%.
“Although VPS35L deficiency had only a very mild impact on the levels of most of the COMMD proteins, COMMD10 levels were decreased by 42% (Figure S1A).”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataVPS26C deletion reduces retromer subunit VPS35 by 39% but does not affect VPS26 and VPS29.
“Retromer subunit VPS35 was significantly reduced by 39%, but the other retromer subunits, VPS26 and VPS29, were not affected by VPS26C deletion (Figure 3C and 3D).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataHepatocyte-specific expression of 3 sgRNAs targeting exon 1 of Vps26c results in efficient editing of the Vps26C locus and a 75% reduction of VPS26C protein levels.
“Hepatocytespecific expression of 3 sgRNAs targeting exon 1 of Vps26c (Figure 3A) resulted in efficient editing of the Vps26C locus, as determined by RT-PCR analysis using primers annealing to the sequence edited by CRISPR/ Cas9 (Figure 3B); this resulted in a 75% reduction of VPS26C protein levels (Figure 3B).”
Quote in the paperSubstantial claim- Rests on an assumption: The sgRNAs targeting Vps26c do not have off-target effects that contribute to the observed phenotype.
It may state two separate claims as one.
Findingown dataVPS35L depletion resulted in a 52% reduction of CCDC22 and a 48% reduction of CCDC93 protein levels.
“This resulted in a 52% and 48% reduction of the protein levels of the CCC core components CCDC22 and CCDC93, respectively (Figure 1C and 1D).”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataVPS26C ablation increases cell surface LDLR expression without affecting total LDLR levels.
“whereas LDLR expression at the cell surface was increased without affecting total LDLR levels (Figure 5C and 5D).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataVPS35L ablation strongly reduces total LDLR and LRP1 levels, as well as their levels at the plasma membrane, in primary hepatocytes.
“VPS35L ablation strongly reduced total LDLR and LRP1 levels, as well as levels at the plasma membrane (Figure 2A)”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataVPS35L deficiency reduces COMMD1-associated CCDC22 levels by 29% but does not affect levels of other CCC subunits associated with COMMD1.
“We found that VPS35L deficiency reduced the levels of CCDC22 by 29% but did not affect the levels of other CCC subunits associated with COMMD1 (Figure 1H).”
- Also stated in: § DISCUSSION · boosted
“We also demonstrated that the composition of the CCC complex is minimally affected upon VPS35L ablation; only the association of CCDC22 with the CCC complex was reduced by 29%, while the other CCC core subunits were unaffected.”
Quote in the paperSubstantial claim- Also stated in: § DISCUSSION · boosted
It may state two separate claims as one.
Findingown datasgRNAs targeting Vps26c strongly downregulate VPS26C protein levels, and hepatic expression of PCSK9-D377Y blunts hepatic LDLR expression.
“Again, expressing the sgRNAs targeting Vps26c strongly downregulated VPS26C protein levels (Figure 6A), and hepatic expression of PCSK9-D377Y blunted hepatic LDLR expression (Figure 6B and 6C).”
Quote in the paperSubstantial claim- Rests on an assumption: AAV-mediated expression of PCSK9-D377Y blunts hepatic LDLR expression without other effects that could explain the phenotype.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Findingown dataIn several studies, only small changes for some subunits of retriever, retromer, and the CCC complex were observed in livers of NAFLD/NASH patients.
“In several studies, only small changes for some of the subunits were observed (Figure S3)”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
FindingcitationHepatic VPS26C deficiency results only in an increase in plasma TG levels, with an effect size comparable to LDLR-deficient mice carrying a mutation in the distal NPxY motif of LRP1.
“In contrast, hepatic VPS26C deficiency results only in an increase in plasma TG levels, with an effect size comparable to LDLR-deficient mice carrying a mutation in the distal NPxY motif of LRP1.56”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim.
PremisecitationHepatic uptake of triglyceride-rich lipoproteins and their remnants highly depends on the LDL receptor (LDLR) and LRP1, both members of the LDLR family.
“Hepatic uptake of these types of TRLs and remnants highly depends on the LDL receptor (LDLR) and LRP1 (LDLR-related protein 1), both members of the LDLR family.5”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationGenetic studies have identified a single nucleotide polymorphism in the LRP1 locus associated with triglyceride levels.
“In addition, genetic studies have identified a single nucleotide polymorphism in the LRP1 locus associated with triglyceride (TG) levels.12,13”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [12]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [13]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim.
PremisecitationA recent study identified retriever as a novel protein complex composed of VPS26C, VPS35L, and VPS29.
“Interestingly, a recent study identified a novel protein complex called retriever, which is composed of VPS26C, VPS35L, and VPS29 (Figure 1A).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationThe association of the CCDC93 variant with reduced LDL cholesterol and lower cardiovascular risk is explained by enhanced functioning of the CCC complex, resulting in improved LDLR recycling.
“This was explained by enhanced functioning of the CCC complex, resulting in improved LDLR recycling.27”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationA common genetic variant in CCC subunit CCDC93 is associated with reduced LDL cholesterol levels and lower risk of myocardial infarction and cardiovascular mortality.
“Furthermore, a common genetic variant in CCC subunit CCDC93 is associated with reduced LDL cholesterol levels, and lower risk of myocardial infarction and cardiovascular mortality.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationSeveral studies have demonstrated a role for hepatic LRP1 in hepatic uptake of chylomicron remnants.
“Although the contribution of hepatic LRP1 to plasma lipid clearance is less clear, several studies have demonstrated a role in the hepatic uptake of chylomicron remnants.[8][9][10][11]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [10]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationRetriever shows structural similarities with retromer and both contain a VPS29 subunit.
“It shows structural similarities with retromer and they both contain a VPS29 subunit.31”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
PremisecitationRetriever likely facilitates receptor recycling through coupling of VPS26C to SNX17, whereas retromer recognizes receptors via SNX27.
“Retriever likely facilitates receptor recycling through coupling of VPS26C to the adaptor protein sorting nexin (SNX) 17, whereas retromer recognizes receptors via the adaptor protein SNX27.31”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationLDLR mediates clearance of LDL particles through binding to apoB, and of TRL remnants such as chylomicron remnants and VLDL remnants through binding of apoE.
“LDLR mediates the clearance of LDL particles through binding to apoB (apolipoprotein B), and of TRL remnants, such as chylomicron remnants and VLDL (very-low-density lipoprotein) remnants through binding of apoE (apolipoprotein E). 6,7”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [6]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [7]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
PremisecitationThe endosomal sorting system plays a crucial role in the functioning of LDLR and LRP1 and in hepatic uptake of lipoproteins.
“but in recent years, it has become clear that the endosomal sorting system also plays a crucial role in their functioning and, consequently, in the hepatic uptake of lipoproteins (reviewed by Wijers et al, 20 Van De Sluis et al, 21”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Wijers et al, 20
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Van De Sluis et al, 21
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Vos et al 22
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim.
PremisecitationPrevious in vitro studies have demonstrated that SNX17 mediates endosomal sorting of cargos containing a NPxY/NxxY-motif in their cytoplasmic domain, including LDLR and LRP1.
“Previous in vitro studies have demonstrated that SNX17 mediates endosomal sorting of cargos containing a NPxY/NxxY-motif in their cytoplasmic domain, including LDLR and LRP1.5,[32][33][34][35][36]”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [5]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [32]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [33]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationLocalization of WASH and CCC complexes to endosomes partially depends on the trimeric protein complex retromer.
“In vitro studies have shown that the localization of the WASH and CCC complexes to endosomes partially depends on the trimeric protein complex retromer (vacuolar protein sorting [VPS] 35, VPS26, VPS29), a key regulator of endosomal cargo”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [28]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [29]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [30]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim.
PremisecitationRetriever physically associates with CCC and WASH complexes at endosomes to form a retromer-independent endosomal sorting pathway.
“Retriever physically associates with CCC and WASH complexes at endosomes to form a retromer-independent endosomal sorting pathway.31”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim.
PremisecitationUpregulation of LDLR is explained as a mechanism to compensate for the loss of LRP1 function.
“In these studies, the upregulation of LDLR was explained as a mechanism to compensate for the loss of LRP1 function.8”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationown dataVPS35L is shared by retriever and CCC complex and is required for plasma cholesterol homeostasis by facilitating the transport of LDLR and LRP1 to the plasma membrane of hepatocytes.
“VPS35L is shared by retriever and CCC complex and is required for plasma cholesterol homeostasis by facilitating the transport of LDLR (low-density lipoprotein receptor) and LRP1 (LDLR-related protein 1) to the plasma membrane of hepatocytes.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Interpretationown dataCCC complex formation does not completely rely on VPS35L but needs VPS35L for its function to transport LDLR and LRP1 from the endosome to the cell surface.
“We demonstrate that CCC complex formation does not completely rely on VPS35L but needs VPS35L for its function to transport LDLR and LRP1 from the endosome to the cell surface”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Study design and conductcitationTo minimize inaccuracies from pooling samples for FPLC, no selection criteria were used to select specific samples, and equal volumes of all individual samples were pooled for each experimental group.
“To minimize inaccuracies as a consequence of pooling samples for FPLC as described in the AHA statement, 44 no selection criteria were used to select specific samples, thus we have pooled equal volumes of all individual samples for each experimental group of mice”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites AHA statement, 44
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationCCC promotes surface expression of both LRP1 and LDLR.
“Whereas CCC promotes surface expression of both LRP1 and LDLR, 24,25”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationSystems biology studies have suggested that CCC and retriever likely form a large evolutionary conserved multiprotein complex, named COMMander.
“In line with this, systems biology studies have suggested that CCC and retriever likely form a large evolutionary conserved multiprotein complex, named COMMander.39”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [39]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationown dataVPS35L participates in CCC complex formation and does not form a distinct protein complex.
“suggesting that VPS35L participates in CCC complex formation, and does not form a distinct protein complex.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Interpretationown dataVPS35L is not a core subunit of the CCC complex, but is a shared component of CCC and retriever.
“Our data therefore favor the model that VPS35L is not a core subunit of the CCC complex, but is a shared component of CCC and retriever.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
InterpretationreasoningThe differential effect on TRL remnants versus VLDL-like particles may be explained by the different composition of these particles, such as the absence of apoB.
“which may be explained by the different composition of these particles, such as the absence of apoB.”
Quote in the paperNot a substantial claimProbably not a substantial claim.
PremisecitationVPS29 is a subunit of retriever and retromer.
“Since VPS29 is a subunit of retriever and retromer, 31”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim.
PremisecitationLDLR can compensate for the loss of LRP1 in the liver.
“As mentioned previously, LDLR can compensate for the loss of LRP1 in the liver.8”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationown dataVPS35L is needed for the physical association between retriever and the CCC complex without having a strong adverse effect on CCC complex composition.
“these data indicate that VPS35L is needed for the physical association between retriever and the CCC complex without having a strong adverse effect on CCC complex composition.”
Quote in the paperSubstantial claimProbably not a substantial claim. It may state two separate claims as one.
PremisecitationHepatocytes in vivo are polarized and contain an apical and basolateral surface with distinct sorting pathways.
“Hepatocytes in vivo are polarized and contain an apical and basolateral surface with distinct sorting pathways 52”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductnone givenTo correct for multiple testing, the Holm-Šídák multiple comparison test was performed in several cases.
“To correct for multiple testing, the Holm-Šídák multiple comparison test was in several cases also performed, as indicated in the figure legends (Figures 1D and 3D; Figure S1A).”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationCCC deficiency reduces levels of both LDLR and LRP1 in the whole-cell lysate and plasma membrane of MEFs and primary hepatocytes, but not in total liver lysates.
“However, this observation is in line with our previous studies, where we observed that CCC deficiency reduces levels of both LDLR and LRP1 in the whole-cell lysate and plasma membrane of MEFs and primary hepatocytes, but not in total liver lysates.24,25”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Study design and conductnone givenData were checked for normality by Shapiro-Wilk test and for equal variance by the F test.
“Data were checked for normality by Shapiro-Wilk test and for equal variance by the F test.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductreasoningMultiple comparison testing was performed in some cases after a parametric t test because the non-parametric test has a minimum P of 0.0286 when n=4/group.
“Since a property of the non-parametric test is that P=0.0286 is the minimum P possible when n=4/group, multiple comparison testing was in some cases also performed after a parametric t test (Figure 1D; Figure S1A).”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Interpretationown dataRetriever subunit VPS26C has a specific role in transport of lipoprotein receptors, as it regulates LRP1 functioning, but not LDLR, to facilitate hepatic uptake of postprandial TRL remnants.
“Conversely, retriever subunit VPS26C has a specific role in transport of lipoprotein receptors, as it regulates LRP1 functioning, but not LDLR, to facilitate hepatic uptake of postprandial TRL remnants.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductown dataNo randomization or blinding methods were used for the animal studies.
“Sample size of each experiment is described in the figure legends, no randomization or blinding methods were used for the animal studies.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Interpretationown dataHepatic loss of VPS35L slightly affects CCC complex formation without having an impact on retromer, but strongly reduces the protein level of retriever component VPS26C and the association between VPS29 and CCC.
“Overall, these findings show that hepatic loss of VPS35L slightly affects CCC complex formation without having an impact on retromer, but strongly reduces the protein level of retriever component VPS26C and the association between of VPS29 and CCC”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Interpretationown dataVPS26C deficiency does not adversely affect the integrity of the CCC complex and retromer, nor the protein levels of VPS35L.
“These data suggest that VPS26C deficiency neither adversely affects the integrity of the CCC complex and retromer, nor the protein levels of VPS35L.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
InterpretationcitationThe decreased LRP1 surface levels can probably be explained by reduced endosomal receptor recycling, resulting in impaired retrieval of the receptor from lysosomal degradation.
“The decreased LRP1 surface levels can probably be explained by reduced endosomal receptor recycling, resulting in impaired retrieval of the receptor from lysosomal degradation.24,25”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationown dataHepatic deletion of VPS26C specifically delays the uptake of postprandial TRL remnants, rather than VLDL-like particles.
“These results suggest that hepatic deletion of VPS26C specifically delays the uptake of postprandial TRL remnants, rather than VLDL-like particles”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Study design and conductreasoningOnly male mice were used, which is a limitation of the current study.
“Only male mice were used to compare our results with previous studies in which we investigated the role of the endosomal sorting machinery in cholesterol homeostasis [24][25][26] ; using only male mice is a limitation of the current study.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [26]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
InterpretationreasoningTaken together, contradictory findings show that neither the molecular organization nor the physiological role of retriever in endosomal sorting are as yet fully understood.
“Taken together, these contradictory findings show that neither the molecular organization nor the physiological role of retriever in endosomal sorting are as yet fully understood.”
Quote in the paperNot a substantial claim- Rests on an assumption: There is no evidence whether retriever is required for the endosomal transport of hepatocytic LDLR and LRP1.
- Rests on an assumption: There is no consensus whether VPS35L is a shared subunit between the 2 complexes or participates in only one of the 2 complexes.
It may state two separate claims as one.
Interpretationown dataRetriever subunit VPS26C selectively controls the recycling of LRP1, but not LDLR, and regulates clearance of postprandial remnant lipoproteins.
“Retriever subunit VPS26C selectively controls the recycling of LRP1, but not low-density lipoprotein receptor, and regulates clearance of postprandial remnant lipoproteins.”
Quote in the paperSubstantial claimProbably not a substantial claim.
PremisecitationIt has recently been reported that VPS35L is a subunit shared by the CCC complex and retriever.
“It has recently been reported that VPS35L is a subunit shared by the CCC complex and retriever 37 (Figure 1A).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [37]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationVPS35L was recognized as forming the CCC complex, together with CCDC22, CCDC93, and the 10 COMMD proteins.
“Initially, VPS35L was recognized as forming the CCC complex, together with CCDC22, CCDC93, and the 10 COMMD proteins.28”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationown dataVPS26C is required for the transport of LRP1, but not LDLR, from the endosome to the plasma membrane.
“Taken together, these findings suggest that VPS26C is required for the transport of LRP1-but not LDLR-from the endosome to the plasma membrane.”
Quote in the paperSubstantial claimProbably not a substantial claim.
Study design and conductcitationThe role of VPS29 was not investigated because loss of VPS29 would negatively affect both retriever and retromer.
“The role of VPS29 was not investigated in the current study, since this subunit is a subunit of retriever and retromer, and loss of VPS29 would therefore negatively affect retriever as well retromer.31”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationown dataHepatic ablation of VPS35L impairs the endosomal transport of LDLR and LRP1 and mimics the hypercholesterolemic phenotype of hepatocyte-specific CCC-deficient mice.
“These data show that hepatic ablation of VPS35L impairs the endosomal transport of LDLR and LRP1 and mimics the hypercholesterolemic phenotype of hepatocyte-specific CCC-deficient mice, 24,25”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationown dataVPS26C is required for hepatic uptake of postprandial TRL by promoting surface expression of LRP1 but not LDLR.
“our data show that retriever subunit VPS26C is required for hepatic uptake of postprandial TRL, by promoting surface expression of LRP1 but not LDLR”
Quote in the paperSubstantial claimProbably not a substantial claim.
PremisecitationPrevious studies have shown that the integrity of the CCC complex is dependent on all its core subunits.
“As previous studies have shown that the integrity of the CCC complex is dependent on all its core subunits, 25,28 we examined”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [28]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationown dataVPS26C specifically facilitates the surface levels of LRP1, but not LDLR.
“VPS26C specifically facilitates the surface levels of LRP1, but not LDLR.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationRetriever has recently been identified as a trimeric protein complex consisting of VPS26C, VPS29, and VPS35L, which is physically associated with the CCC complex.
“Retriever has recently been identified as a trimeric protein complex consisting of VPS26C, VPS29, and VPS35L (Figure 1A), which is physically associated with the CCC complex.31”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Interpretationnone givenIt cannot be ruled out that other mechanisms explain the increased plasma TG levels upon hepatic ablation of Vps26c in an LDLR-deficient background.
“However, we cannot rule out other mechanisms explaining the increased plasma TG levels upon hepatic ablation of Vps26c in a LDLR-deficient background.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The authors may not put it forward as true. The paper’s conclusions may not depend on it.
PremisecitationEndosomal recycling of LDLR and LRP1 is orchestrated by a direct interaction between VPS26C and the adaptor protein SNX17.
“Interestingly, it has been postulated that endosomal recycling of LDLR and LRP1 is orchestrated by a direct interaction between VPS26C and the adaptor protein SNX17.31”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationHepatic LPL plays an important role in TG clearance.
“For example, it has been shown that hepatic LPL (lipoprotein lipase) plays also an important role in TG clearance.53,54”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [53]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [54]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationLoss of hepatic PID1 increases LDLR levels, and hepatic PID1 inactivation in LDLR knockout mice results in decreased postprandial TRL clearance, with subsequent plasma TG accumulation.
“Loss of hepatic PID1 increases LDLR levels, and hepatic PID1 inactivation in LDLR knockout mice results in decreased postprandial TRL clearance, with subsequent plasma TG accumulation.11”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationown dataVPS26C specifically facilitates the transport of LRP1, but not LDLR, from the endosomes to the plasma membrane, and hereby controls postprandial TG levels in plasma.
“VPS26C specifically facilitates the transport of LRP1, but not of LDLR, from the endosomes to the plasma membrane, and hereby controls postprandial TG levels in plasma.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Interpretationown dataVPS26C does not act together with SNX17 to facilitate endosomal recycling of both members of the LDLR family, but likely only of LRP1.
“our data may implicate that VPS26C does not act together with SNX17 to facilitate endosomal recycling of both members of the LDLR family, but likely only of LRP1.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationHepatic LPL deficiency increases plasma TG due to a decrease in postprandial TG clearance.
“Hepatic LPL deficiency increases plasma TG due to a decrease in postprandial TG clearance.55”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
PremisecitationMice carrying a mutation in the distal NPxY motif of LRP1 show hepatic upregulation of LDLR, and on an LDLR-deficient background these LRP1 mutant mice show elevated plasma TG levels due to delayed postprandial TRL clearance.
“Like hepatic VPS26C-deficient mice, mice carrying a mutation in the distal NPxY motif of LRP1 show hepatic upregulation of LDLR, and on an LDLRdeficient background these LRP1 mutant mice show elevated plasma TG levels due to delayed postprandial TRL clearance.56”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim.
PremisecitationThe distal NPxY motif of LRP1 is essential for postprandial TRL clearance.
“The distal NPxY motif of LRP1 is essential for postprandial TRL clearance.56”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
PremisecitationLRP1 contains a proximal NPTY motif recognized by SNX17, as well as a distal NPVY motif; LDLR has only one NPVY motif, which can also be recognized by SNX17.
“LRP1 contains a proximal NPTY motif, which is recognized by SNX17, as well as a distal NPVY motif; LDLR has only one NPVY motif, which can also be recognized by SNX17.32,[34][35][36]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 32,[34][35][36]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
PremisecitationThe translocation of LRP1 is likely mediated by insulin, as insulin can phosphorylate the tyrosine residue within the distal NPxY motif, resulting in dissociation of LRP1-adaptor protein PID1.
“This translocation is likely mediated by insulin, as insulin can phosphorylate the tyrosine residue within the distal NPxY motif, resulting in dissociation of LRP1-adaptor protein PID1.11”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
Interpretationnone givenVPS35L participates in retriever and the CCC complex, while VPS26C is only a component of retriever.
“VPS35L participates in retriever and the CCC complex, while VPS26C is only a component of retriever.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. The quote only partly states this claim.
Study design and conductown dataThe immunoblot data in Figure 5C and 5E represent 2 independent experiments.
“Data represent 2 independent experiments.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationMutations in CCDC22 and WASHC5 cause hypercholesterolemia.
“We previously demonstrated that mutations in CCDC22 and WASHC5 cause hypercholesterolemia, [24][25][26]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [26]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationPathogenic variants in VPS35L have been reported in patients with a 3C/Ritscher-Schinzel (RSS)-like syndrome.
“Recently, Kato et al 58 reported pathogenic variants in VPS35L in patients with a 3C/Ritscher-Schinzel (RSS)-like syndrome.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [58]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
InterpretationreasoningIt cannot be ruled out that the decreased TG clearance can be explained by other mechanisms.
“we can therefore not rule out that the decreased TG clearance can be explained by other mechanisms.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationPID1 sequesters LRP1 in endosomes under fasting conditions.
“PID1 sequesters LRP1 in endosomes under fasting conditions.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationMutations in WASHC4 and WASHC5 have been identified in patients with non-syndromic autosomal recessive intellectual disability and 3C/RSS, respectively, and mutations in CCDC22 cause X-linked recessive intellectual disability with clinical features of 3C/RSS.
“For example, mutations in WASHC4 and WASHC5 have been identified in patients with non-syndromic autosomal recessive intellectual disability 60 and 3C/RSS, 61 respectively, and mutations in CCDC22 cause X-linked recessive intellectual disability (XLID) with clinical features of 3C/RSS.62”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [60]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [61]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [62]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationLRP1 translocates in a postprandial state from the endosomes to the cell surface.
“It has been demonstrated that LRP1 translocates in a postprandial state from the endosomes to the cell surface.57”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationA homozygous nonsense variant in VPS26C has been described in individuals with a pleiotropic syndrome characterized by neurodevelopmental defects, growth failure, skeletal anomalies, and distinctive facial features.
“Furthermore, a homozygous nonsense variant in VPS26C was described in individuals with a pleiotropic syndrome characterized by neurodevelopmental defects, growth failure, skeletal anomalies, and distinctive facial features.59”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [59]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim.
PremisecitationHepatic loss of LPL results in elevated plasma cholesterol levels.
“However, hepatic loss of LPL also results in elevated plasma cholesterol levels, 55”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [55]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim.
PremisecitationSNX17 regulates endosomal recycling by binding with its FERM-domain to NPxY motifs in intracellular domains of various proteins, including LDLR family members LDLR and LRP1.
“SNX17 regulates endosomal recycling by binding with its FERM-domain to NPxY motifs in intracellular domains of various proteins, including LDLR family members LDLR and LRP1.[32][33][34][35][36]”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [32]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [33]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [34]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [35]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [36]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
PremisecitationHepatic CCC knockout on an LDLR-deficient background displays a marked increase in both plasma cholesterol and TG levels, similar to the phenotype of hepatic LRP1-deficient mice on an LDLR knockout background.
“The latter model displays a marked increase in both plasma cholesterol and TG levels, 25 which is similar to the phenotype of hepatic LRP1-deficient mice on an LDLR knockout background, 8”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
The paper relies on this without support.
There is no evidence whether retriever is required for the endosomal transport of hepatocytic LDLR and LRP1.
“However, to date, there is no evidence whether retriever is required for the endosomal transport of hepatocytic LDLR and LRP1.”
The paper relies on this without support.
There is no consensus whether VPS35L is a shared subunit between the 2 complexes or participates in only one of the 2 complexes.
“To date, there is no consensus whether VPS35L is a shared subunit between the 2 complexes or participates in only one of the 2 complexes.”
The paper relies on this without support.
The sgRNAs targeting Vps26c do not have off-target effects that contribute to the observed phenotype.
“Hepatocytespecific expression of 3 sgRNAs targeting exon 1 of Vps26c (Figure 3A) resulted in efficient editing of the Vps26C locus, as determined by RT-PCR analysis using primers annealing to the sequence edited by CRISPR/ Cas9 (Figure 3B); this resulted in a 75% reduction of VPS26C protein levels (Figure 3B).”
The paper relies on this without support.
AAV-mediated expression of PCSK9-D377Y blunts hepatic LDLR expression without other effects that could explain the phenotype.
“hepatic expression of PCSK9-D377Y blunted hepatic LDLR expression (Figure 6B and 6C).”
The paper relies on this without support.
The apoB48/apoB100 ratio is a valid marker for remnant lipoproteins.
“the apoB48/apoB100 ratio, a marker for remnant lipoproteins, in plasma of hepatic VPS26C-deficient mice with blunted LDLR levels was increased compared with control mice (Inset Figure 6F).”
The paper relies on this without support.
The VLDL-like particles used are representative of endogenous VLDL particles for assessing hepatic uptake.
“we also assessed the hepatic uptake of VLDLlike particles.42”
The paper relies on this without support.
The retriever protein complex consists of VPS26C, VPS35L, and VPS29.
“The retriever protein complex, consisting of VPS26C, VPS35L, and VPS29, was recently described as a novel endosomal sorting complex in the CCC-WASH axis to promote recycling of receptors back to the cell surface.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mutations in WASHC5, CCDC22 and VPS35L all result in hypercholesterolemia in humans, thought to be due to abnormal LDL clearance secondary to defects in LDL receptor recycling.
“It is worth noting that mutations in WASHC5, CCDC22 and VPS35L all result in hypercholesterolemia in humans thought to be due to abnormal LDL clearance secondary to defects in LDL receptor recycling, a phenotype also seen in mouse models of liver deficiency of Ccdc22, Vps35l and Commd1 [5, 7, 30–32].”
From CCDC22 mutations that impair COMMD binding cause attenuated 3C/Ritscher-Schinzel syndrome (2025) · cites this paper as [32]
The Discussion says mutations in CCDC22 and WASHC5 cause hypercholesterolemia, but explicitly says whether VPS35L mutations are associated with increased plasma lipid levels remains to be evaluated. The section on hepatic VPS35L loss links impaired LDL receptor recycling and increased cholesterol to mice, not to humans with VPS35L mutations. (LLM, conf=0.91)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Sucrose-gradient result points to the wrong figure panel
MinorThe text cites Figure 1E for the distribution of CCC subunits after sucrose-gradient fractionation, but the figure description assigns the fractionation experiment to Figure 1G. Figure 1E instead reports VPS26C protein levels.
“Despite the reduced levels of CCDC22 and CCDC93 (Figure 1C and 1D), loss of hepatocytic VPS35L did not affect their distribution (Figure 1E).”
“E, VPS26C protein levels in control and VPS35L-deficient livers,”
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4 · Cited by 34,218
Ference, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx144 · Cited by 3,962
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Willer (2013) · doi:10.1038/ng.2797 · Cited by 2,983
CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
Platt, R. J., Chen, S., Zhou, Y., Yim, M. J., Swiech, L., Kempton, H. R., Dahlman, J. E., Parnas, O., Eisenhaure, T. M., Jovanovic, M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.014 · Cited by 2,001
Genevestigator V3: A Reference Expression Database for the Meta‐Analysis of Transcriptomes
Hrúz, T., Laule, O., Szabo, G., Wessendorp, F., Stefan Bleuler, A., Oertle, L., Widmayer, P., Gruissem, W., & Philip Zimmermann, B. (2008) · Advances in Bioinformatics · doi:10.1155/2008/420747 · Cited by 1,910
Receptor-Mediated Endocytosis: Concepts Emerging from the LDL Receptor System
Goldstein, J. L., Brown, M. S., Anderson, R. G. W., Russell, D. W., & Schneider, W. J. (1985) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.01.110185.000245 · Cited by 1,600
Coated pits, coated vesicles, and receptor-mediated endocytosis
Goldstein, J. L., Anderson, R. G. W., & Brown, M. S. (1979) · Nature · doi:10.1038/279679a0 · Cited by 1,532
Protein Sensors for Membrane Sterols
Goldstein, J. L., DeBose-Boyd, R. A., & Brown, M. S. (2006) · Cell · doi:10.1016/j.cell.2005.12.022 · Cited by 1,517
Triglycerides and cardiovascular disease
Nordestgaard, B. G., & Varbo, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61177-6 · Cited by 1,419
Zolotukhin, S., Byrne, B. J., Mason, E. G., Zolotukhin, I., Potter, M., Chesnut, K. A., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,321
Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979
LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor
Zelcer, N., Hong, C., Boyadjian, R., & Tontonoz, P. (2009) · Science · doi:10.1126/science.1168974 · Cited by 848
Zhang, D.-W., Lagace, T. A., Garuti, R., Zhao, Z., McDonald, M., Horton, J. D., Cohen, J. C., & Hobbs, H. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702027200 · Cited by 788
Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice
Lagace, T. A., Curtis, D. E., Garuti, R., McNutt, M. C., Park, S. W., Prather, H. B., Anderson, N. N., Ho, Y. K., Hammer, R. E., & Horton, J. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29383 · Cited by 681
Merkel, M., Eckel, R. H., & Goldberg, I. J. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200015-jlr200 · Cited by 520
Rohlmann, A., Gotthardt, M., Hammer, R. E., & Herz, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1240 · Cited by 455
Ishibashi, S., Herz, J., Maeda, N., Goldstein, J. L., & Brown, M. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4431 · Cited by 430
Nathwani, A. C., Gray, J. T., Ng, C. Y., Zhou, J., Spence, Y., Waddington, S. N., Tuddenham, E. G. D., Kemball‐Cook, G., McIntosh, J., Boon‐Spijker, M., et al. (2005) · Blood · doi:10.1182/blood-2005-10-4035 · Cited by 421
Retriever is a multiprotein complex for retromer-independent endosomal cargo recycling
McNally, K. E., Faulkner, R., Steinberg, F., Gallon, M., Ghai, R., Pim, D., Langton, P., Pearson, N., Danson, C. M., Nägele, H., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3610 · Cited by 346
Daugherty, A., Tall, A. R., Daemen, M. J. A. P., Falk, E., Fisher, E. A. A., García‐Cardeña, G., Lusis, A. J., Owens, A. P., Rosenfeld, M. E., & Virmani, R. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atv.0000000000000062 · Cited by 321
Induction of Atherosclerosis in Mice and Hamsters Without Germline Genetic Engineering
Bjørklund, M. M., Hollensen, A. K., Hagensen, M. K., Dagnæs‐Hansen, F., Christoffersen, C., Mikkelsen, J. G., & Bentzon, J. F. (2014) · Circulation Research · doi:10.1161/circresaha.114.302937 · Cited by 317
COMMD Proteins, a Novel Family of Structural and Functional Homologs of MURR1
Burstein, E., Hoberg, J. E., Wilkinson, A. S., Rumble, J. M., Csomos, R. A., Komarck, C. M., Maine, G. N., Wilkinson, J. C., Mayo, M. W., & Duckett, C. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501928200 · Cited by 258
Poirier, S., Mayer, G., Poupon, V., McPherson, P. S., Desjardins, R., Ly, K., Asselin, M.-C., Day, R., Duclos, F. J., Witmer, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.037085 · Cited by 254
Phillips-Krawczak, C. A., Singla, A., Starokadomskyy, P., Deng, Z., Osborne, D. G., Li, H., Dick, C. J., Gomez, T. S., Koenecke, M., Zhang, J.-S., et al. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-06-1073 · Cited by 246
Harbour, M. E., Breusegem, S. Y., & Seaman, M. N. J. (2012) · Biochemical Journal · doi:10.1042/bj20111761 · Cited by 238
CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL
Bartuzi, P., Billadeau, D. D., Favier, R., Rong, S., Dekker, D., Fedoseienko, A., Fieten, H., Wijers, M., Levels, J. H., Huijkman, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms10961 · Cited by 205
Self-citationEndosomal receptor trafficking: Retromer and beyond
Wang, J., Fedoseienko, A., Chen, B., Burstein, E., Jia, D., & Billadeau, D. D. (2018) · Traffic · doi:10.1111/tra.12574 · Cited by 180
Rensen, P. C. N., Herijgers, N., Netscher, M. H., Meskers, S. C. J., Eck, M. V., & van Berkel, T. J. C. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37190-x · Cited by 163
Self-citationRole of membrane traffic in the generation of epithelial cell asymmetry
Apodaca, G. L., Gallo, L. I., & Bryant, D. M. (2012) · Nature Cell Biology · doi:10.1038/ncb2635 · Cited by 161
Sorting nexin 17 facilitates LRP recycling in the early endosome
van Kerkhof, P., Lee, J., McCormick, L., Tetrault, E., Lu, W., Schoenfish, M., Oorschot, V., Strous, G. J., Klumperman, J., & Bu, G. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600756 · Cited by 148
Lipoprotein receptors – an evolutionarily ancient multifunctional receptor family
Dieckmann, M., Dietrich, M. F., & Herz, J. (2010) · Biological Chemistry · doi:10.1515/bc.2010.129 · Cited by 135
Stockinger, W., Sailler, B., Strasser, V., Recheis, B., Fasching, D., Kahr, L., Schneider, W. J., & Nimpf, J. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf435 · Cited by 130
Merkel, M., Weinstock, P. H., Chajek‐Shaul, T., Radner, H., Yin, B., Breslow, J. L., & Goldberg, I. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2912 · Cited by 130
Fedoseienko, A., Wijers, M., Wolters, J. C., Dekker, D., Smit, M., Huijkman, N., Kloosterhuis, N., Klug, H., Schepers, A., Willems van Dijk, K., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312004 · Cited by 126
Self-citationSingla, A., Fedoseienko, A., Giridharan, S. S. P., Overlee, B. L., Lopez, A., Jia, D., Song, J., Huff-Hardy, K., Weisman, L., Burstein, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12221-6 · Cited by 113
van de Sluis, B., Wijers, M., & Herz, J. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000411 · Cited by 111
Self-citationLaatsch, A., Merkel, M., Talmud, P. J., Grewal, T., Beisiegel†, U., & Heeren, J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.046 · Cited by 106
Systems-wide Studies Uncover Commander, a Multiprotein Complex Essential to Human Development
Mallam, A. L., & Marcotte, E. M. (2017) · Cell Systems · doi:10.1016/j.cels.2017.04.006 · Cited by 94
Functional properties of hepatocytes in vitro are correlated with cell polarity maintenance
Zeigerer, A., Wuttke, A., Marsico, G., Seifert, S., Kalaidzidis, Y. L., & Zerial, M. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.11.027 · Cited by 91
Burden, J. J., Sun, X.-M., García, A. B. G., & Soutar, A. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313689200 · Cited by 82
Scotti, E., Calamai, M., Goulbourne, C. N., Zhang, L., Hong, C., Lin, R. R., Choi, J., Pilch, P. F., Fong, L. G., Zou, P., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01716-12 · Cited by 81
Ropers, F. G., Derivery, E., Hu, H., Garshasbi, M., Karbasiyan, M., Herold, M. J., Nürnberg, G., Ullmann, R., Gautreau, A. M., Sperling, K., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr158 · Cited by 81
Foley, E. M., Gordts, P. L. S. M., Stanford, K. I., Gonzales, J. C., Lawrence, R., Stoddard, N., & Esko, J. D. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.301637 · Cited by 77
Elliott, A. M., Simard, L. R., Coghlan, G., Chudley, A. E., Chodirker, B. N., Greenberg, C. R., Burch, T., Ly, V., Hatch, G. M., & Zelinski, T. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101715 · Cited by 70
Donoso, M., Cancino, J., Lee, J., van Kerkhof, P., Retamal, C., Bu, G., Gonzalez, A., Cáceres, A., & Marzolo, M.-P. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-08-0805 · Cited by 69
Liver-Specific Commd1 Knockout Mice Are Susceptible to Hepatic Copper Accumulation
Vonk, W. I. M., Bartuzi, P., de Bie, P., Kloosterhuis, N., Wichers, C. G. K., Berger, R., Haywood, S., Klomp, L. W. J., Wijmenga, C., & van de Sluis, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029183 · Cited by 61
Self-citationThe life cycle of the low-density lipoprotein receptor: insights from cellular and in-vivo studies
Wijers, M., Kuivenhoven, J. A., & van de Sluis, B. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000157 · Cited by 55
Self-citationKolanczyk, M., Krawitz, P., Hecht, J., Hupalowska, A., Miaczynska, M., Marschner, K., Schlack, C., Emmerich, D., Kobus, K., Kornak, U., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.109 · Cited by 54
Farfán, P., Lee, J., Larios, J., Sotelo, P., Bu, G., & Marzolo, M. (2013) · Traffic · doi:10.1111/tra.12076 · Cited by 51
Loregger, A., Raaben, M., Nieuwenhuis, J., Tan, J. M. E., Jae, L. T., van den Hengel, L. G., Hendrix, S., van den Berg, M., Scheij, S., Song, J.-Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14811-1 · Cited by 51
Gordts, P. L. S. M., Reekmans, S. M., Lauwers, A., Dongen, A. V., Verbeek, L., & Roebroek, A. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.192211 · Cited by 47
Regulation of plasma lipid homeostasis by hepatic lipoprotein lipase in adult mice
Liu, G., Xu, J., Liu, D., Ding, Q., Liu, M.-N., Chen, R., Fan, M., Zhang, Y., Zheng, C., Zou, D., et al. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m065011 · Cited by 44
The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance
Wijers, M., Zanoni, P., Liv, N., Vos, D. Y., Jäckstein, M. Y., Smit, M., Wilbrink, S., Wolters, J. C., van der Veen, Y. T., Huijkman, N., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126462 · Cited by 44
Self-citationKato, K., Oka, Y., Muramatsu, H., Vasilev, F. F., Otomo, T., Oishi, H., Kawano, Y., Kidokoro, H., Nakazawa, Y., Ogi, T., et al. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106213 · Cited by 42
Vos, D. Y., & van de Sluis, B. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101146 · Cited by 35
Self-citationGordts, P. L. S. M., Bartelt, A., Nilsson, S. K., Annaert, W. G., Christoffersen, C., Nielsen, L. B., Heeren, J., & Roebroek, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038330 · Cited by 33
Fischer, A. W., Albers, K., Krott, L. M., Hoffzimmer, B., Heine, M., Schmale, H., Scheja, L., Gordts, P. L. S. M., & Heeren, J. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.07.010 · Cited by 29
Rimbert, A., Dalila, N., Wolters, J. C., Huijkman, N., Smit, M., Kloosterhuis, N., Riemsma, M., van der Veen, Y., Singla, A., van Dijk, F., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz727 · Cited by 24
Self-citationPolarisation, key to good localisation
van Beest, M., Robben, J. H., Savelkoul, P. J. M., Hendriks, G., Devonald, M. A. J., Konings, I. B. M., Lagendijk, A. K., Karet, F. E., & Deen, P. M. T. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.007 · Cited by 19
Jaeschke, A., Haller, A. M., Cash, J. G., Nam, C., Igel, E., Roebroek, A., & Hui, D. Y. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120001141 · Cited by 10
Beetz, C., Ameziane, N., Kdissa, A., Karageorgou, V., Bauer, P., Suleiman, J., Sutton, V. R., & El‐Hattab, A. W. (2019) · Clinical Genetics · doi:10.1111/cge.13690 · Cited by 6
Flagged first, then by citations
Research works printed but not linked: 2
- 10.1161/atvbaha.113.301637.hepatic · DOI
- RStudio Team. RStudio: Integrated Development for R. RStudio, PBC, Boston, MA; 2020. http://www.rstudio.com/
Cited by
Sorted by citations
Structural organization of the retriever–CCC endosomal recycling complex
Boesch, D. J., Singla, A., Han, Y., Kramer, D. A., Liu, Q., Suzuki, K., Juneja, P., Zhao, X., Long, X., Medlyn, M. J., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01184-4 · Cited by 52
Mechanism and regulation of cargo entry into the Commander endosomal recycling pathway
Butkovič, R., Walker, A. P., Healy, M. D., McNally, K. E., Liu, M., Veenendaal, T., Kato, K., Liv, N., Klumperman, J., Collins, B. M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50971-0 · Cited by 26
Selective cargo and membrane recognition by SNX17 regulates its interaction with Retriever
Martín-González, A., Méndez-Guzmán, I., Zabala-Zearreta, M., Quintanilla, A., García-López, A., Martínez-Lombardía, E., Albesa-Jové, D., Acosta, J. C., & Lucas, M. (2025) · EMBO Reports · doi:10.1038/s44319-024-00340-1 · Cited by 15
Potential Roles of SNX17, Rab11, and Rab5 in LDLR Recycling
Zhao, X., Long, S., Zhu, M., Hao, H., Liao, Y., Zhang, C., & Liu, Z. (2025) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.125.322498 · Cited by 8
Selheim, F., Aasebø, E., Reikvam, H., Bruserud, Ø., & Hernandez-Valladares, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105080 · Cited by 6
Heida, A., van Dijk, T. H., Smit, M., Koehorst, M., Koster, M. H., Kloosterhuis, N., Havinga, R., Bloks, V. W., Wolters, J. C., de Bruin, A., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159445 · Cited by 1
Self-citationJian, L., Wang, B., Gao, Y., Xue, Y., Guan, Y., Qu, Y., Liu, K., Yan, L., Li, S., & Luo, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143021 · Cited by 1
Thorne, A. M., Geng, Y., Lantinga, V. A., Smit, M., Kuivenhoven, J. A., Porte, R. J., Kuipers, F., Olinga, P., Wolters, J. C., & de Meijer, V. E. (2025) · Physiological Reports · doi:10.14814/phy2.70348 · Cited by 1
Self-citationLi, S., Wu, J., Zhou, Y., Wang, C., Xie, L., Liu, S., Su, Y., He, W., Chen, H., Zhong, W.-W., et al. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i10.109898 · Cited by 1
Zhang, B., Loaiza, N., Rimbert, A., Oldoni, F., Blauw, L. L., Rensen, P. C. N., Martinez, L. O., Robert, J., von Eckardstein, A., Wolters, J. C., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf254 · Cited by 1
Self-citationCCDC22 mutations that impair COMMD binding cause attenuated 3C/Ritscher-Schinzel syndrome
Singla, A., Rogers, C., Touma, M.-J., El-Najjar, Y., Colley, A., Boesch, D. J., Billadeau, D. D., Gecz, J., Chen, B., & Burstein, E. (2025) · BMC Medical Genomics · doi:10.1186/s12920-025-02168-7 · Cited by 1
Li, Q., Qi, K., Wu, S., Shen, A., & Zhao, L. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117351 · Cited by 1
Verzijl, C. R. C., Struik, D., Gerding, A., Eilers, R. E., Thomas, R., Koster, M. H., Langelaar‐Makkinje, M., Smit, M., Huijkman, N., Havinga, R., et al. (2026) · Gastro Hep Advances · doi:10.1016/j.gastha.2026.100881
Self-citationThe COPI coatomer influences LDL receptor activity, hepatic lipid storage, and apoB secretion
Panteloglou, G., Robert, J., Smit, M., Huijkman, N., Kloosterhuis, N., Law, C. S., Woods, B., Othman, A., Kleber, M. E., Delgado, G., et al. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.121887
Self-citationKrishnamurthy, K. A., Xiao, R., Rutten, M. G. S., Bos, T., Bleeker, A., Zhang, M., de Vries, H. I., Koster, M. H., Huijkman, N., Smit, M., et al. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102393
Self-citationVerzijl, C. R. C., Barbosa, M. G., Vos, D. Y., Heida, A., Caillaud, A., Vanharanta, L., Ge, X., Tissink, J. J., Koster, M. H., Smit, M., et al. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102456
Self-citation
Metadata
- Authors
- Vos, D. Y., Wijers, M., Smit, M., Huijkman, N., Kloosterhuis, N. J., Wolters, J. C., Tissink, J. J., Pronk, A. C. M., Kooijman, S., Rensen, P. C. N., Kuivenhoven, J. A., & van de Sluis, B.
- Affiliations
- University Medical Center Groningen (NL)
- University Hospital Heidelberg (DE)
- Leiden University Medical Center (NL)
- ORCID
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2023-01
- Volume
- 43
- Issue
- 1
- Pages
- e29-e45
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W4308679124
- Cited by
- 16
- References
- 62
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 3 · 2023: 2
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Site cant be reached (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- Stichting De Cock-Hadders
- European Commission (953489)
- H2020 Marie Skłodowska-Curie Actions (953489)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- VPS29, LDL receptor, LRP1, endosomal transport, hepatic lipoprotein metabolism, serum cholesterol, PCSK9, liver-specific knockout mice
- MeSH terms
- Proprotein Convertase 9, Animals, Humans, Lipoproteins, Receptors, LDL, Triglycerides, Mice, Knockout, Hepatocytes, Low Density Lipoprotein Receptor-Related Protein-1, Vesicular Transport Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-08, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-08 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review